HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women

AIDS

Volumn 10, Issue 4, 1996, Pages 413-417

  Langley, Carol L ^a   Benga De, Elisabeth ^b   Critchlow, Cathy W ^a   Ndoye, Ibra ^b   Mbengue Ly, Mame Dieumbe ^b   Kuypers, Jane ^a   Woto Gaye, Gisele ^c   Mboup, Souleymane ^c   Bergeron, Christine ^d   Holmes, King K ^a   Kiviat, Nancy B ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Institute for Social Hygiene   (Senegal)

^c UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^d Inst of Pathol and Appl Cytology   (France)

Author keywords

Cervical dysplasia; Cervical intraepithelial neoplasia; Cervical squamous intraepithelial lesions; HIV 1; HIV 2; Human papillomavirus

Indexed keywords

CD4 ANTIGEN;

ADULT; ARTICLE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTITUTION; SENEGAL; SOUTHERN BLOTTING; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

EID: 9244250413     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199604000-00010     Document Type: Article

References (23)

1. Parkin DM, Laara E, Muir CS: Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988, 41:184-197.
2. Mandelblatt JS, Fahs M, Garibaldi K, Senie RT, Peterson HB: Association between HIV infection and cervical neoplasia: implications for clinical care of women at risk for both conditions. AIDS 1992, 6:173-178.
3. Feingold AR, Vermund SH, Burk RD, et al.: Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 1990, 3:896-903.
4. Vermund SH, Kelley KF, Klein RS, et al.: High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol 1991, 165:392-400.
5. Laga M, Icenogle JP, Marsella R, et al.: Genital papillomavirus infection and cervical dysplasia - opportunistic complications of HIV infection. Int J Cancer 1992, 50:45-48.
6. ter Meulen J, Eberhardt HC, Luande J, et al.: Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, East Africa. Int J Cancer 1992, 51:515-521.
7. Coll-Seck A, Faye MA, Critchlow CW, et al.: Cervical intraepithelial neoplasia and human papillomavirus infection among Senegalese women seropositive for HIV 1 or HIV 2 or seronegative for HIV. Int J STD AIDS 1994, 5:189-193.
8. Williams AB, Darragh TM, Vranizan K, Ochia C, Moss AR, Palefsky JM: Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol 1994, 83:205-211.
9. Ho GYF, Burk RD, Fleming I, Klein RS: Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer 1994, 56:788-792.
10. Schrager LK, Friedland GH, Maude D, et al.: Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 1989, 2:570-575.
11. Schafer A, Friedmann W, Mielke M, Schwartlander B, Koch MA: The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol 1991, 164:593-599.
12. Maggwa BN, Hunter DJ, Mbugua S, Tukei P, Mati JK: The relationship between HIV infection and cervical intraepithelial neoplasia among women attending two family planning clinics in Nairobi, Kenya. AIDS 1993, 7:733-738.
13. Wright TC, Ellerbrock TV, Chiasson MA, Van Devanter N, Sun X and the New York Cervical Disease Study: Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol 1994, 84:591-597.
14. Klein RS, Ho GYF, Vermund SH, Fleming I, Burk RD: Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection. J Infect Dis 1994, 170:1404-1409.
15. National Cancer Institute Workshop: The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnoses. JAMA 1989, 262:931-934.
16. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM: The use of polymerase chain reaction amplification for the detection of genital human papillomavirus. In Cancer Cells 7/Molecular Diagnostics of Human Cancer. Cold Spring Harbor: Cold Spring Harbor Laboratory; 1989:209-214.
17. Lorincz AT, Temple GF, Patterson JA, Jenson AB, Kurmer RJ, Lancaster WD: Correlation of cellular atypia and human papillomavirus deoxyribonucleic acid sequences in exfoliated cells of the uterine cervix. Obstet Gynecol 1986, 68:508-512.
18. Marlink R, Kanki P, Thior I, et al.: Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994, 265:1587-1590.
19. Bauer HM, Ting Y, Greer CE, et al.: Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991, 265:472-477.
20. Schiffman MH: Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 1992, 84:394-398.
21. Hildesheim A, Gravitt P, Schiffman MH, et al.: Determinants of genital human papillomavirus infection in low-income women in Washington, DC. Sex Transm Dis 1993, 20:279-285.
22. Bauer HM, Hildesheim A, Schiffman MH, et al.: Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 1993, 20:274-278.
23. Kiviat NB, Critchlow CW, Kurman RJ: Reassessment of the morphological continuum of cervical intraepithelial lesions: does it reflect different stages in the progression to cervical carcinoma? IARC Sci Publ 1992, 119:59-66.